BRIEF-Pliant Therapeutics Announces Upcoming Presentation Of Phase 1 Clinical Trial Of PLN-101095 In Patients With Solid Tumors At The 2026 Aacr Annual Meeting
Reuters
Mar 18
BRIEF-Pliant Therapeutics Announces Upcoming Presentation Of Phase 1 Clinical Trial Of PLN-101095 In Patients With Solid Tumors At The 2026 Aacr Annual Meeting
March 18 (Reuters) - Pliant Therapeutics Inc PLRX.O:
PLIANT THERAPEUTICS ANNOUNCES UPCOMING PRESENTATION OF PHASE 1 CLINICAL TRIAL OF PLN-101095 IN PATIENTS WITH SOLID TUMORS AT THE 2026 AACR ANNUAL MEETING
Source text: ID:nGNX6ndHZn
Further company coverage: PLRX.O
((Reuters.Briefs@thomsonreuters.com;))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.